Catalyst Pharmaceutical Partners, Inc.

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PVWmIL+HK27bAp0VxrCu1D7Hb1LzjGyhCfQxT3MJtwdNl7/ZR6QhZwdim7ehAkY6 gt/pnk8b1ugFsh/ih7phiA== 0000950144-06-009718.txt : 20061227 0000950144-06-009718.hdr.sgml : 20061227 20061023175235 ACCESSION NUMBER: 0000950144-06-009718 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20061023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 220 MIRACLE MILE STREET 2: SUITE 234 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 220 MIRACLE MILE STREET 2: SUITE 234 CITY: CORAL GABLES STATE: FL ZIP: 33134 CORRESP 1 filename1.htm Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc.
220 Miracle Mile
Suite 234
Coral Gables, Florida 33134

October 23, 2006

VIA EDGAR

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E., Mail Stop 6010
Washington, DC 20549
Attn: Jeffrey Reidler, Assistant Director


Re:		Catalyst Pharmaceutical Partners, Inc. Registration Statement on Form S-1 Commission File No. 333-136039

Dear Mr. Reidler:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Catalyst Pharmaceutical Partners, Inc. (the “Company”) requests that the effectiveness of the above-referenced Registration Statement be accelerated at 10:00 a.m. on Tuesday, October 24, 2006, or as soon as possible thereafter.


	Sincerely,
	/s/ Patrick J. McEnany
	Patrick J. McEnany
	President and Chief Executive Officer Catalyst Pharmaceutical Partners, Inc.

-----END PRIVACY-ENHANCED MESSAGE-----